In summary, patients with anti-IFN-γ AAbs often suffer from recurrent infections like progressive dNTM, deep-seated mycoses and even chronic recurrent bacterial infections that are unresponsive to standard antimicrobial therapy. This evidence concerns the gene IFNG and opportunistic mycosis.